HONG KONG ECONOMIC JOURNAL FEATURE

Summary:

MetTactics, a pioneering biotech company, has gained significant media exposure in the Hong Kong Economic Journal for its groundbreaking chip technology that revolutionizes cancer diagnostics. Led by a team of experts, MetTactics has developed a metastasis-on-a-chip (MoC) that enables the detection and identification of highly metastatic cancer cells. This innovative chip technology offers a cost-effective and efficient solution for early cancer detection, providing valuable insights for precise medication and treatment strategies. With its commitment to advancing precision medicine, MetTactics is poised to make a significant impact in the field of cancer diagnostics and contribute to improving patient outcomes.